1. Home
  2. XNCR

XNCR

Xencor Inc.

as 04-01-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 1997 Country:
United States
United States
Employees: N/A City: PASADENA
Market Cap: N/A IPO Year: 2013
Target Price: $34.13 AVG Volume (30 days): 772.2K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.58 EPS Growth: N/A
52 Week Low/High: $9.65 - $27.24 Next Earning Date: 05-08-2025
Revenue: $110,493,000 Revenue Growth: -36.72%
Revenue Growth (this year): 4.14% Revenue Growth (next year): 25.12%

XNCR Daily Stock ML Predictions

Stock Insider Trading Activity of Xencor Inc. (XNCR)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Dahiyat Bassil I XNCR PRESIDENT & CEO Mar 10 '25 Sell $13.60 19,716 $268,080.42 465,419
Desjarlais John R XNCR SR. VICE PRESIDENT & CSO Mar 10 '25 Sell $13.60 9,697 $131,851.08 236,574
Eckert Celia XNCR SVP, GENERAL COUNSEL Mar 10 '25 Sell $13.60 5,740 $78,047.35 63,507
Valente Nancy XNCR EVP, Chief Development Officer Mar 10 '25 Sell $13.60 2,565 $34,876.56 53,785

Share on Social Networks: